BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35150011)

  • 1. High serum exosomal long non-coding RNA DANCR expression confers poor prognosis in patients with breast cancer.
    Shi W; Jin X; Wang Y; Zhang Q; Yang L
    J Clin Lab Anal; 2022 Mar; 36(3):e24186. PubMed ID: 35150011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer.
    Han P; Zhao J; Gao L
    J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
    Liu Y; Zhang M; Liang L; Li J; Chen YX
    Int J Clin Exp Pathol; 2015; 8(9):11480-4. PubMed ID: 26617879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
    Na-Er A; Xu YY; Liu YH; Gan YJ
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating lncRNA DANCR as a potential auxillary biomarker for the diagnosis and prognostic prediction of colorectal cancer.
    Shen X; Xue Y; Cong H; Wang X; Fan Z; Cui X; Ju S
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32159208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.
    Zhang KJ; Tan XL; Guo L
    Mol Oncol; 2020 Feb; 14(2):309-328. PubMed ID: 31860165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
    Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
    Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer.
    Ding XZ; Zhang SQ; Deng XL; Qiang JH
    Technol Cancer Res Treat; 2021; 20():1533033821990060. PubMed ID: 33550924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of lncRNA DANCR expression in human cancers: a systematic review and meta-analysis.
    Liu W; Wang QP; Guo J
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 30910838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Breast Cancer Diagnosis.
    Zhong G; Wang K; Li J; Xiao S; Wei W; Liu J
    Onco Targets Ther; 2020; 13():2563-2571. PubMed ID: 32273726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.
    Zhou H; Shen W; Zou H; Lv Q; Shao P
    J Int Med Res; 2020 Jul; 48(7):300060520934297. PubMed ID: 32660285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
    Li YW; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma.
    Wang T; Zhu H; Xiao M; Zhou S
    J Clin Lab Anal; 2021 Nov; 35(11):e23959. PubMed ID: 34612554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer.
    Xu H; Zhou J; Tang J; Min X; Yi T; Zhao J; Ren Y
    J Clin Lab Anal; 2020 Aug; 34(8):e23323. PubMed ID: 32274858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
    Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
    Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA-DANCR: A valuable cancer related long non-coding RNA for human cancers.
    Thin KZ; Liu X; Feng X; Raveendran S; Tu JC
    Pathol Res Pract; 2018 Jun; 214(6):801-805. PubMed ID: 29728310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.
    Wang J; Yang K; Yuan W; Gao Z
    Med Sci Monit; 2018 Dec; 24():9307-9316. PubMed ID: 30576305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
    Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
    Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.